Please assess the completion status of the following clinical trial:

Trial Title: Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects between 18 and 65 years of age, with diagnosis of major depressive disorder, as defined by DSM-IV-TR criteria~* The current depressive episode must be equal to or greater than 8 weeks in duration~* Subjects must report a history for the current depressive episode of an inadequate response to at least one and no more than three adequate antidepressant treatments.~Exclusion Criteria:~* Females who are breast-feeding and/or who have a positive pregnancy test result prior to receiving study drug.~* Subjects who report an inadequate response to more than three adequate trials of antidepressant treatments during current depressive episode at a therapeutic dose for an adequate duration.~* Subjects with a current Axis I (DSM-IV-TR) diagnosis of:~  * Delirium, dementia,amnestic or other cognitive disorder~ * Schizophrenia, schizoaffective disorder, or other psychotic disorder~ * Bipolar I or II disorder~ * Subjects with a clinically significant current Axis II (DSM-IV-TR)~ * diagnosis of borderline, antisocial, paranoid, schizoid, schizotypal or histrionic personality disorder.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): OPC-34712 + ADT
- 2 (Type: PLACEBO_COMPARATOR): Placebo + ADT

Based on this trial design, predict the completion outcome and termination type (if applicable).